

₹2,999.00
Pentoxifylline 400 mg (Prolonged Release)
VASOPLAN PR Tablets – Pentoxifylline Prolonged Release Tablets IP 400 Mg is a Pentoxifylline Prolonged Release Tablets IP 400 Mg, indicated for the management of peripheral vascular disorders and microcirculatory disturbances. Pentoxifylline is a xanthine derivative that improves blood rheology by enhancing red blood cell deformability, reducing blood viscosity, and inhibiting platelet aggregation. The prolonged-release matrix ensures sustained therapeutic drug levels, providing consistent improvement in tissue oxygenation and peripheral blood flow throughout the day.
Marketed by: Wonne International Pvt. Ltd.
• Improved Blood Rheology — Enhances red blood cell flexibility and reduces whole blood viscosity, allowing better flow through narrowed or damaged blood vessels.
• Anti-Platelet & Anti-Thrombotic Action: Inhibits platelet aggregation and reduces fibrinogen levels, lowering the risk of microvascular thrombosis and ischemic events.
• Enhanced Tissue Oxygenation: Improves microcirculation and oxygen delivery to ischemic tissues, relieving symptoms of claudication, pain, and tissue damage.
• Prolonged Release Advantage: Controlled drug delivery over an extended period maintains steady plasma levels, reduces dosing frequency, and improves patient compliance.
• Renal & Hepatic Protective Potential: Emerging evidence supports its role in reducing oxidative stress and inflammation in diabetic nephropathy and hepatic fibrosis.
• Vascular Surgery & Angiology
• Diabetology & Endocrinology
• Nephrology & Renal Medicine
• Neurology & Stroke Rehabilitation
• General Medicine & Internal Medicine
• Healthcare practitioner
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.
| Pack |
|---|
Rosuvastatin 10mg + Aspirin 75mg + Clopidogrel 75 mg
Reviews
There are no reviews yet.